Delivery Order SPE2DB25D9321-SPE2DB25FQWPL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count units. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries a firm fixed-price contract structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $10,375.53 for 30 Nuplazid 34 mg capsules by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a continuation of pharmaceutical supply services to the Department of Defense healthcare system. The contract carries...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NUPLAZID 34 mg capsules (30-count units). This firm fixed-price delivery order, issued on August 7, 2025, with completion targeted for August 28, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,375.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 20, 2025. The contract covers the supply of Nuplazid 34 mg capsules in quantities of 30, with a firm fixed-price structure and an ultimate completion date of September 11, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract, valued at $10,093.50, to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S to support the medical supply needs of the agency. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery contract, SPE2DB, with the Defense Logistics Agency, which has a potential value...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $10,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of December 9, 2024, is for the delivery of Nuplazid 34 mg capsules. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $10,375.53 firm fixed-price contract is for the delivery of Nuplazid 34 mg capsules, with a completion date of July 7, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which runs through December 31, 2025. The contract is for the provision of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,210,999 units of the pharmaceutical product Nuplazid 34 mg capsule 30s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a...
- SPE2DB25D9321Indefinite Delivery Contract
- SPE2DB25D9321-SPE2DB25FQWPLDelivery Order
The Defense Logistics Agency issued a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in 30-count packaging. This delivery order was awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, utilizing firm fixed-price pricing with no set-aside designation. The order represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency, a significant $500 million single-award vehicle valid through November 2026 that enables the agency to procure comprehensive pharmaceutical products supporting military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its specialized focus on delivering branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates consistent success in securing delivery orders across diverse pharmaceutical categories, ranging from contraceptive devices and oncology treatments to injections and specialty medications. This particular delivery order for Nuplazid, a psychiatric medication, exemplifies the company's role in supporting the medical needs of military healthcare facilities across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/8/25 |